Elaia
Founded in 2002, Elaia is a Paris-based venture capital firm focused on the digital economy and deep tech. With over €700m under management, it invests in high-potential disruptive startups from early financing rounds to global leadership emergence. The team offers close, proactive support to entrepreneurs, leveraging over 75 years of cumulative experience in both venture capital and digital industries.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Simulation
Zymvol Biomodeling
Seed Round in 2025
Zymvol accelerates the discovery & development of new industrial enzymes through computer simulations.
Zymvol Biomodeling
Seed Round in 2023
Zymvol accelerates the discovery & development of new industrial enzymes through computer simulations.
Sim&Cure
Series A in 2019
Sim&Cure develops software solutions for medical device manufacturers, focusing on endovascular and aneurysm treatments. Its key products include Sim&Size for optimal cerebral device sizing, StentDeviceSizing (STsize) for laser-cut stent deployment simulation, and FlowDiverterSize (FDsize) for predicting aneurysm treatment outcomes. Founded in 2014, the company is headquartered in Grabels, France.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.